| Host: |
Rabbit |
| Applications: |
WB/IHC/IF/IP/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Phospho-Nuclear factor NF-kappa-B p105 subunit-Ser907 (874-923 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence, Immunoprecipitation and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300IP 2-5 ug mg/lysateELISA 1:20000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
NFKB1 |
| Gene ID: |
4790 |
| Uniprot ID: |
NFKB1_HUMAN |
| Immunogen Region: |
874-923 aa |
| Specificity: |
Phospho-NF Kappa B-p105 (S907) Polyclonal Antibody detects endogenous levels of NF Kappa B-p105 protein only when phosphorylated at S907. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human NF-kappaB p105/p50 around the phosphorylation site of Ser907 at the amino acid range 874-923 |
| Function | NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling.active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105. Nuclear factor NF-kappa-B p105 subunit: P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B. Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105. Nuclear factor NF-kappa-B p50 subunit: Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor. Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. |
| Protein Name | Nuclear Factor Nf-Kappa-B P105 SubunitDna-Binding Factor Kbf1Ebp-1Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 1 Cleaved Into - Nuclear Factor Nf-Kappa-B P50 Subunit |
| Database Links | Reactome: R-HSA-1169091Reactome: R-HSA-1810476Reactome: R-HSA-193692Reactome: R-HSA-202424Reactome: R-HSA-209560Reactome: R-HSA-2559582Reactome: R-HSA-2871837Reactome: R-HSA-3134963Reactome: R-HSA-3214841Reactome: R-HSA-381340Reactome: R-HSA-445989Reactome: R-HSA-448706Reactome: R-HSA-5603029Reactome: R-HSA-5607764Reactome: R-HSA-5621575Reactome: R-HSA-5660668Reactome: R-HSA-5684264Reactome: R-HSA-6798695Reactome: R-HSA-844456Reactome: R-HSA-8853884Reactome: R-HSA-9020702Reactome: R-HSA-933542Reactome: R-HSA-9609690Reactome: R-HSA-9660826Reactome: R-HSA-9692916 |
| Cellular Localisation | Nuclear Factor Nf-Kappa-B P105 Subunit: CytoplasmNuclear Factor Nf-Kappa-B P50 Subunit: NucleusCytoplasmAssociation With Nfkbia Inhibitor (I-Kappa-B)Promotes Its Retention In The Cytoplasm In An Inactive FormTranslocates Into The Nucleus Following Nfkbia Degradation |
| Alternative Antibody Names | Anti-Nuclear Factor Nf-Kappa-B P105 Subunit antibodyAnti-Dna-Binding Factor Kbf1 antibodyAnti-Ebp-1 antibodyAnti-Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 1 Cleaved Into - Nuclear Factor Nf-Kappa-B P50 Subunit antibodyAnti-NFKB1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
